Figure 2
ROC curves for analytes in plasma for the prediction of more severe acute GVHD and NRM for patients in cohort 2, using the best model analytes given in Table 3.
ROC curves for analytes in plasma for the prediction of more severe acute GVHD and NRM for patients in cohort 2, using the best model analytes given in Table 3.
